Is Atorvastatin Superior to Other Statins? Analysis of the Clinical Trials with Atorvastatin Having Cardiovascular Endpoints

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 2, 2006-05 ,pp. : 143-153

Bentham Science Publishers

Access to resources Recommend Favorite

A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study)

By Zhu Jun-ren   Tomlinson Brian   Ro Young Moo   Sim Kui-Hian   Lee Yuan-Teh   Sriratanasathavorn Charn  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3055-3068

Informa Healthcare

Access to resources Recommend Favorite

Economic impacts attributable to the early clinical benefit of atorvastatin therapy – a US managed care perspective

By Straka Robert J.   Mamdani Muhammad   Damen Joep   Kuntze C. Erik E.   Liu Larry Z.   Botteman Marc F.   Koren Michael J.  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1517-1529

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Clinical Irrelevance of PK Differences in Atorvastatin Using PK/PD Models Derived From Literature‐Based Meta‐Analyses

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 101-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis

By Reynolds Matthew W.   Shibata Atsuko   Zhao Sean   Jones Natalie   Fahrbach Kyle   Goodnough Lawrence Tim  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite